The Limited Times

Now you can see non-English news...

Merck has applied for authorization of its Covid pill in the United States

2021-10-11T11:33:03.618Z

This request concerns the drug called molnupiravir, intended for the treatment of adult patients with mild to moderate forms of Covid-19.



The American laboratory Merck announced on Monday that it had filed an authorization request with the American authorities for its pill against Covid-19, which could constitute a major advance in the fight against the pandemic.

Read also Merck: the impact of the pandemic on sales begins to fade

This request concerns Merck's drug, dubbed molnupiravir, for the treatment of adult patients with mild to moderate forms of Covid-19 who are at risk of progressing to severe forms and / or hospitalization, the company said in a statement.

Source: lefigaro

All business articles on 2021-10-11

You may like

Trends 24h

Latest

© Communities 2019 - Privacy